Department of Medicine

February 7, 2024

VUMC study finds molecular switch key to repair of kidney damage

Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.

By Bill Snyder
February 2, 2024

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials.

By Jill Clendening
February 1, 2024

A biomarker for early Type 2 diabetes

Genetic analyses suggest that branched chain amino acids may be a sensitive biomarker of early or subclinical Type 2 diabetes and could be used to identify risk and implement preventive measures.

By Bill Snyder
January 30, 2024

Four physician-scientists from VUMC receive national early-career awards

Four Vanderbilt physician-scientists have received awards from the American Society for Clinical Investigation.

By Bill Snyder
January 24, 2024

Stokes Peebles appointed to the National Advisory Allergy and Infectious Diseases Council

Vanderbilt’s Stokes Peebles, MD, has been appointed to the National Advisory Allergy and Infectious Diseases Council.

By Bill Snyder
January 23, 2024

VUMC establishes Realizing Accelerated Progress, Investigation, Implementation, and Dissemination in Learning Health Systems (RAPID-LHS) Center

The new center, supported by a $5 million grant from the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute will focus on training scientists and supporting research to minimize gaps between the generation of clinical evidence, implementation of proven interventions and development of informed public health policy.

By Jill Clendening
January 22, 2024

Molecular profiles of tissue plus circulating tumor DNA can better guide cancer care

Vanderbilt research indicates that adding liquid biopsy testing for circulating tumor DNA mutations increases targetable mutation detection rates.
By Tom Wilemon
January 18, 2024

Beloved VUMC colleague and acclaimed scientist David Robertson mourned

David Robertson, MD, a beloved leader and mentor, and a pioneer in the clinical research of blood pressure disorders at Vanderbilt University Medical Center, died Jan. 12 at his home in Nashville. He was 76.
By Bill Snyder and Nancy Humphrey
January 11, 2024

Comprehensive Care Clinic’s Ruby Gala set for Feb. 10

The Vanderbilt Comprehensive Care Clinic, Nashville’s original nonprofit medical home for people living with HIV, will hold its annual Ruby Gala on Saturday, Feb. 10, 2024, at Marathon Music Works.
By Bill Snyder
January 10, 2024

Stanford, Essentia Health join VUMC-based clinical research network

The STAR Clinical Research Network, based at Vanderbilt University Medical Center (VUMC), has added two new partners — Essentia Health, a Minnesota-based rural health care system, and Stanford University School of Medicine, one of the country’s leading academic medical centers.
By Bill Snyder
January 9, 2024

Innovations improve the lives of patients with IBD

Two recent innovations — point-of-care intestinal ultrasound and functional medicine — are improving the lives of patients at the Vanderbilt Inflammatory Bowel Disease Clinic at Vanderbilt Health One Hundred Oaks.
By Bill Snyder, Carol Poston, and Meredith Carr
January 4, 2024

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

By Jill Clendening
January 4, 2024

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.
By Tom Wilemon
1 2 3 4 5 6 … 101